基于探针测试生物传感器的自动化快速荧光免疫法检测血清可溶性PD-1
本研究基于探针测试(TOP)生物传感器,采用一对鼠抗PD-1单克隆抗体,开发了自动化快速荧光免疫法检测血清可溶性PD-1(sPD-1),20分钟内完成,精密度变异系数小于10%,线性范围2-3000 pg/mL,与现有ELISA试剂盒相关性良好(r=0.92,p<0.0001)。该法测得慢性乙肝、肝硬化和肝癌患者sPD-1水平均显著高于健康对照(p<0.0001)。
要点
- TOP免疫法20分钟内自动化检测sPD-1,精密度CV<10%,线性范围2-3000 pg/mL。
- 与ELISA相关性良好(r=0.92,p<0.0001),慢性肝病及肝癌患者sPD-1显著升高。
- 目前无FDA批准的sPD-1常规检测方法,该法有潜力用于临床。
核心结论
- 基于TOP生物传感器的自动化快速荧光免疫法可定量检测血清sPD-1,分析性能可接受,与ELISA相关性好,具有临床潜力。
研究设计与样本
- 开发性研究方法,采用一对鼠抗PD-1单克隆抗体(经生物膜干涉技术评估)建立TOP生物传感器荧光免疫法,评估灵敏度、线性和重复性,并与现有ELISA试剂盒比较,检测健康人及慢性乙肝、肝硬化、肝癌患者sPD-1水平。
主要发现
- TOP法20分钟内完成,精密度变异系数小于10%,线性范围2至3000 pg/mL。
- TOP法与ELISA法结果相关性良好(r=0.92,p<0.0001)。
- 慢性乙肝、肝硬化和肝癌患者sPD-1水平均显著高于健康对照(p<0.0001)。
关键数值与推荐
- 精密度:变异系数小于10%。
- 线性范围:2至3000 pg/mL。
- 与ELISA相关性:r=0.92,p<0.0001。
- 患者组与健康对照比较:p<0.0001。
临床怎么用
- 该自动化快速免疫法可替代手工ELISA用于血清sPD-1检测,适用于肝病患者的辅助监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Soluble programmed death-1 (sPD-1) plays an essential role in the pathogenesis and progression of various diseases, including chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC). Currently, there is no Food and Drug Administration-approved sPD-1 immunoassay available for routine clinical testing. Most sPD-1 detections employed enzyme-linked immunosorbent assay (ELISA) method for research purpose, which is complicated by intensive manual operation and cannot achieve automatic detection. Therefore, we aimed to develop an automated, rapid immunoassay for sPD-1 measurement based on testing-on-a-probe (TOP) biosensors and evaluate its performance in patients with hepatic diseases. METHODS: We developed an automatic fluorescent immunoassay using TOP biosensors using a pair of mouse anti-PD-1 monoclonal antibodies (mAbs), which were evaluated by biolayer interferometry. The sensitivity, linearity, and repeatability of the novel immunoassay were analyzed, and its compatibility with an established ELISA kit was evaluated. Further, we quantified sPD-1 level in healthy individuals as well as patients with CHB, hepatic cirrhosis, and HCC. RESULTS: The TOP assay to quantify sPD-1 was developed and performed on an automatic fluorescent analyzer within 20 min, which showed good precision with coefficients of variation less than 10% and good linearity ranging from 2 to 3,000 pg/mL. The results tested by our TOP assay correlated well with the established ELISA assay (r=0.92, p<0.0001). Using our TOP assay, sPD-1 was significantly elevated in patients with chronic hepatitis, hepatic cirrhosis and hepatocarcinoma if compared to healthy control, respectively (p<0.0001). CONCLUSIONS: An automated, rapid fluorescent immunoassay to quantify serological sPD-1 protein using TOP biosensors was developed and showed acceptable analytical performance including precision, linearity, and good correlation with the established ELISA assay, with the great potential in clinical practice.
引用
- Zhang J, Chen L, Xu Q, et al. An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors. Clin Chem Lab Med. 2022. PMID: 35535427. doi:10.1515/cclm-2022-0166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。